1-(3-Bromophenyl)cyclopropanecarboxylic acid, 97.0%, 10g

Methyl 3-[4-(trifluoromethyl)pyridin-2-yl]benzoate, 95.0%, 1g

(S)-4-Benzyl-2-oxazolidinone>98.0%(GC)5g

Ethyl 2-oxocyclopentanecarboxylate, 97.0%, 1kg

Bis(4-aminophenyl) terephthalate, 95.0%, 100g

GC capillary column ROTI®Cap-FFAP, 50 m, 0.32 mm, 0.50 µm, 1 Piece(s)

5-(4-PHENYL-5-(TRIFLUOROMETHYL)THIOPHEN-2-YL)-3-(3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOLE, 95%, 10mg

Nitazoxanide, 95.0%, 100g

3,5-Dibromo-4-methylphenol, 98.0%, 5g

2,5-Dichlorobenzenesulfonamide, 97.0%, 25g

4-(4-chloro-2,6-dimethylquinolin-3-yl)butan-2-one, 95.0%, 1g

(2-Hydroxy-5-methylphenyl)triphenylphosphonium Iodide>98.0%(T)(HPLC)5g

3-Fluoro-5-nitropyridine, 95.0%, 1g